SCHEMBL8618668

SCHEMBL8618668

COc1cc(OC)c2c(C(=O)NC(N)=Nc3ccccc3)ccnc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMO Q99835 10/20 0.43
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
LMNA P02545 3/20 0.42
PSMD14 O00487 1/20 0.42
IMPDH2 P12268 1/20 0.41
SCN2A Q99250 2/20 0.40
SCN5A Q14524 1/20 0.40
KDM4E B2RXH2 3/20 0.39
POLB P06746 1/20 0.38
MAPT P10636 1/20 0.38
ALDH1A1 P00352 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
SCNN1A P37088 1/20 0.38
GMNN O75496 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
HPGD P15428 1/20 0.37
NFKB1 P19838 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8615174 0.99 SMO (0.42) SMONPC1RAB9ALMNAPSMD14
SCHEMBL8617435 0.87 KDM4E (0.38) NPC1RAB9ALMNAKDM4EPOLB
SCHEMBL8620636 0.86 NPC1 (0.49) SMONPC1RAB9ALMNAPSMD14
SCHEMBL8619835 0.86 SMO (0.49) SMONPC1RAB9ALMNAPSMD14
SCHEMBL8616307 0.84 SMO (0.43) SMONPC1RAB9ALMNAPSMD14
SCHEMBL8616502 0.83 KDM4E (0.48) NPC1RAB9ALMNASCN2AKDM4E
SCHEMBL8617949 0.82 SMO (0.46) SMONPC1RAB9ALMNAPSMD14
SCHEMBL8620870 0.82 SRC (0.47) SMONPC1RAB9ALMNAPSMD14
SCHEMBL8614046 0.82 SMO (0.49) SMONPC1RAB9ALMNAPSMD14
SCHEMBL8620947 0.81 KDM4E (0.60) NPC1RAB9ALMNASCN2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0726254-B1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS (JP) 1998-05-06 EP disclosed
US-5627193-A MEDICAL DIAGNOSIS, CARDIOVASCULAR DIAORDERS AND PROTECTION OF ORGANS FOR TRANSPLANTATION MITSUI TOATSU CHEMICALS, INC. (JP) 1997-05-06 US disclosed
EP-0726254-A1 Quinoline-4-carbonylguanidine derivates, process for producing the same and pharmaceutical preparations containing the compounds MITSUI TOATSU CHEMICALS, Inc. (JP) 1996-08-14 EP disclosed